Efficacy and Safety of RTX-GRT7039 in Adult Subjects With Knee Osteoarthritis

NCT ID: NCT05248386

Last Updated: 2025-08-12

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

469 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-08-26

Study Completion Date

2024-11-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A double-blind, randomized, placebo-controlled, parallel-group, multi-site, clinical trial to confirm the efficacy and safety of repeated injections of RTX-GRT7039 versus placebo in patients who have pain associated with osteoarthritis of the knee despite standard of care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This trial comprises a total observation period of up to 52 weeks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

RTX-GRT7039

Participants will receive intra-articular injections of RTX-GRT7039 during the 52-week double-blind treatment period.

Group Type EXPERIMENTAL

RTX-GRT7039

Intervention Type DRUG

RTX-GRT7039 intra-articular injection.

Placebo

Participants will receive intra-articular injections of placebo matching to RTX-GRT7039 during the 52-week double-blind treatment period.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Placebo matching RTX-GRT7039 intra-articular injection.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

RTX-GRT7039

RTX-GRT7039 intra-articular injection.

Intervention Type DRUG

Placebo

Placebo matching RTX-GRT7039 intra-articular injection.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The participant has given written informed consent to participate.
* The participant is 18 years of age or older at the Screening Visit.
* The participant has a diagnosis of osteoarthritis of the knee based on American College of Rheumatology criteria and functional capacity class of I to III.
* There is a documented history indicating that participant has insufficient pain relief with previous Standard of Care.

Exclusion Criteria

* The participant has past joint replacement surgery of the index knee.
* The participant has a history of significant trauma or surgery (e.g., open or arthroscopic) to the index knee within 12 months of Screening.
* The participant has periarticular pain from any cause other than osteoarthritis, including referred pain, bursitis, or tendonitis.
* The participant has clinical hip osteoarthritis on the side of the index knee.
* The participant has pre-existing osteonecrosis, subchondral insufficiency fracture, atrophic osteoarthritis, severe bone on bone osteoarthritis, knee pain attributable to disease other than osteoarthritis, or the participant has rapidly progressing osteoarthritis (RPOA) Type I or Type II.
* The participant has significant malalignment of anatomical axis (medial angle formed by the femur and tibia) of the target knee (varus \>10, valgus \>10) by X-ray as assessed by independent Central Readers at Screening Visit.
* The participant has other conditions that could affect trial endpoint assessments of the index knee.
* The participant has current clinically significant disease(s) or condition(s) that may affect efficacy or safety assessments, or any other reason which, in the investigator's opinion, may preclude the participant's participation for the full duration of the trial.
* The participant has a history of hypersensitivity to resiniferatoxin (RTX) or any similar component (capsaicin, chili peppers).
* The participant is currently participating or was participating in another investigational drug trial within 3 months prior to the Screening Visit.
* The participant is an employee of the investigator or trial site, with direct involvement in the proposed trial or other trials under the direction of that investigator or trial site or is a family member of the employees or the investigator.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Grünenthal GmbH

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cook Street Medical Clinic

Victoria, British Columbia, Canada

Site Status

Dr. M. B. Jones

Victoria, British Columbia, Canada

Site Status

Aggarwal and Associates Limited

Brampton, Ontario, Canada

Site Status

Malton Medical Research

Mississauga, Ontario, Canada

Site Status

GRMO (Groupe de Recherche en Rhumatologie et Maladies Osseuses) Inc.

Sainte-Foy, Quebec, Canada

Site Status

Diex Research Sherbrooke Inc.

Sherbrooke, Quebec, Canada

Site Status

Diex Recherche Victoriaville Inc.

Victoriaville, Quebec, Canada

Site Status

Lekarna U Svate Anny

Písek, Czech Republic, Czechia

Site Status

Revmatologie s.r.o.

Brno, , Czechia

Site Status

Interni A Revmatologicka Ambulance

Břeclav, , Czechia

Site Status

Vesalion s.r.o.

Ostrava, , Czechia

Site Status

Revmatologicka Ambulance

Ostrava, , Czechia

Site Status

Ortopedicko-traumatologicka ambulance

Písek, , Czechia

Site Status

CCBR Czech Prague, s.r.o

Prague, , Czechia

Site Status

CCR Prague, s.r.o

Prague, , Czechia

Site Status

Revmatologicka ambulance

Prague, , Czechia

Site Status

Thomayerova Nemocnice (TN)

Prague, , Czechia

Site Status

Fakultni Thomayerova nemocnice s poliklinikou

Prague, , Czechia

Site Status

Revmatologicka ambulance

Prague, , Czechia

Site Status

EUC Klinika

Prague, , Czechia

Site Status

Db Ortopedie s.r.o

Příbram, , Czechia

Site Status

PV-MEDICAL s.r.o. Revmatologicka ambulance

Zlín, , Czechia

Site Status

Centre Hospitalier Universitaire d'Amiens-Picardie - Site Sud

Amiens, , France

Site Status

CHU Amiens Nord

Amiens, , France

Site Status

Hopital Edouard Herriot

Lyon, , France

Site Status

CHU Nimes Cedex

Nîmes, , France

Site Status

Hopital Saint antoine

Paris, , France

Site Status

Cochin Hospital-Paris Descartes University

Paris, , France

Site Status

Hopitaux de Paris (AP-HP) - Groupe Hospitalier Cochin -Assistance Publique

Paris, , France

Site Status

Hopital Lariboisiere,Hospitalier Universitaire Nord

Paris, , France

Site Status

Praxis Dr. med. Stephan Grunert

Eichstätt, , Germany

Site Status

Medizentrum Essen Borbeck

Essen, , Germany

Site Status

HRF Hamburger Rheuma Forschungszentrum

Hamburg, , Germany

Site Status

Ortho-Zentrum Karlsruhe

Karlsruhe, , Germany

Site Status

Velocity Clinical Research Leipzig GmbH

Leipzig, , Germany

Site Status

AmBeNet, Practice Dr. Dr. med. Hans-Detlev Stahl

Leipzig, , Germany

Site Status

Centrum fuer Diagnostik und Gesundheit (CDG)

München, , Germany

Site Status

Praxis-Reinfeld-Mitte

Reinfeld, , Germany

Site Status

AOU-Careggi

Florence, , Italy

Site Status

AOU-Careggi

Florence, , Italy

Site Status

Universita degli Studi della Campania Luigi Vanvitelli - Azienda Ospedaliera Universitaria

Naples, , Italy

Site Status

Dipartimento Di Scienze Ortopediche, Traumatologiche, Riabilitative E Plastico-Ricostruttive

Napoli, , Italy

Site Status

IRCCS Istituto Clinico Humanitas

Rozzano, , Italy

Site Status

AOU Citta della Salute e della Scienza di Torino

Torino, , Italy

Site Status

Funabashi Municipal Medical Center

Funabashi-shi, Chiba, Japan

Site Status

Kamagaya General Hospital

Kamagaya, Chiba, Japan

Site Status

Hamanomachi Hospital

Fukuoka, Fukuoka, Japan

Site Status

Souseikai Fukuoka Mirai Hospital

Fukuoka, Fukuoka, Japan

Site Status

Seiwa-kai medical corporation Hiroshima clinic

Hiroshima, Hiroshima, Japan

Site Status

Kosei General Hospital

Mihara, Hiroshima, Japan

Site Status

Kosei General Hospital

Mihara-shi, Hiroshima, Japan

Site Status

Hakodate Central General Hospital

Hakodate, Hokkaido, Japan

Site Status

Sapporo Maruyama Orthopedic Hospital

Sapporo, Hokkaido, Japan

Site Status

KKR Sapporo Medical Center

Sapporo, Hokkaido, Japan

Site Status

Sapporo kotoni Orthopedies

Sapporo, Hokkaido, Japan

Site Status

Kinashi Obayashi Hospital

Takamatsu, Kagawa-ken, Japan

Site Status

Japan Organization of Occupational Health and Safety Yokohama Rosai Hospital

Yokohama, Kanagawa, Japan

Site Status

Yokohoma Rosai Hospital

Yokohama, Kanagawa, Japan

Site Status

Social Medical Care Corporation Hosei-kai Marunouchi Hospital

Nagano, Matsumoto-shi Nagano, Japan

Site Status

KKR Tohoku Kosai Hospital

Sendai, Miyagi, Japan

Site Status

Nakajo Orthopedic Clinic

Sendai, Miyagi, Japan

Site Status

Marunouchi Hospital

Matsumoto, Nagano, Japan

Site Status

KKR Tohoku Kosai Hospital

Aoba-ku, Sendai-shi, Japan

Site Status

Otsu City Hospital

Ōtsu, Shiga, Japan

Site Status

Shimane University Hospital

Izumo, Shimane, Japan

Site Status

Shimane University Hospital

Izumo, Shimane, Japan

Site Status

Japanese Red Cross Hamamatsu Hospital

Hamamatsu, Shizuoka, Japan

Site Status

Juntendo University Hospital

Bunkyo-Ku, Tokyo, Japan

Site Status

Juntendo University Graduate School of Medicine

Bunkyo-ku, Tokyo, Japan

Site Status

Kitasato University Kitasato Institute Hospital

Minato-ku, Tokyo, Japan

Site Status

Shirahama Hamayu Hospital

Nishimura, Wakayama, Japan

Site Status

Juntendo University Hospital

Tokyo, , Japan

Site Status

Medical Corporation Teda Ooimachi Orthopaedic Surgery and Surgery Clinic

Tokyo, , Japan

Site Status

Morales Vargas Centro de Investigacion SC

León, Guanajuato, Mexico

Site Status

Centro Integral en Reumatologia, SA de CV

Guadalajara, Jalisco, Mexico

Site Status

Clinstile, S.A. de C.V

Cuauhtémoc, Mexico City, Mexico

Site Status

Consultorio de Reumatologia

Gustavo Adolfo Madero, Mexico City, Mexico

Site Status

CINTRE, Centro de Investigacion y Tratamiento Reumatologico S.C.

Mexico City, Mexico City, Mexico

Site Status

Dr. Miguel Cortes Hernandez MD, Office of

Cuernavaca, Morelos, Mexico

Site Status

Centro de Investigacion de Tratamientos Innovadores de Sinaloa S.C.

Culiacán, Sinaloa, Mexico

Site Status

Investigacion y Biomedicina de Chihuahua

Chihuahua City, , Mexico

Site Status

Medisch Spectrum Twente (MST) - Enschede Haaksbergerstraat

Enschede, KZ, Netherlands

Site Status

PT&R

Beek, Limburg, Netherlands

Site Status

Spaarne Gasthuis (Kennemer Gasthuis)

Hoofddorp, , Netherlands

Site Status

Synexus Poznan Medical Center

Poznan, Greater Poland Voivodeship, Poland

Site Status

Pratia MCM Krakow

Krakow, Lesser Poland Voivodeship, Poland

Site Status

Reumed Spolka z o.o. Zespol poradni Specjalistycznych Filia Nr 1 Wallenroda

Lublin, Lublin Voivodeship, Poland

Site Status

KO-MED Centra Kliniczne Lublin II

Zamość, Lublin Voivodeship, Poland

Site Status

Makmed Nzoz

Nadarzyn, Masovian Voivodeship, Poland

Site Status

NZOZ Lecznica MAK-MED S.C.

Nadarzyn, Masovian Voivodeship, Poland

Site Status

Gabinet Internistyczno-Reumatologiczny Piotr Adrian Klimiuk

Bialystok, Podlaskie Voivodeship, Poland

Site Status

Synexus Polska Sp. z o.o. Oddzial w Gdansku

Gdansk, Pomeranian Voivodeship, Poland

Site Status

INTER CLINIC Piotr Adrian Klimiuk

Bialystok, , Poland

Site Status

Synexus Gdynia

Gdynia, , Poland

Site Status

Mazowieckie Centrum Badan Klinicznych

Grodzisk Mazowiecki, , Poland

Site Status

Synexus Katowice Medical Center

Katowice, , Poland

Site Status

Centrum Medyczne Pratia Katowice

Katowice, , Poland

Site Status

Malopolskie Centrum Kliniczne

Krakow, , Poland

Site Status

St Centrum Medyczne Plejady

Krakow, , Poland

Site Status

Synexus Polska Sp. z o.o. Oddzial w Lodzi

Lodz, , Poland

Site Status

KO-MED Centra Kliniczne Lublin II

Lublin, , Poland

Site Status

Synexus Polska Spolka z ograniczona odpowiedzialnoscia Oddzial we Wroclawiu

Wroclaw, , Poland

Site Status

Centrum Medyczne Kuba-Med Zamosc

Zamość, , Poland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada Czechia France Germany Italy Japan Mexico Netherlands Poland

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-005029-26

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

U1111-1268-7314

Identifier Type: OTHER

Identifier Source: secondary_id

KF7039-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Tanezumab in Osteoarthritis of the Knee
NCT00733902 COMPLETED PHASE3